×
En revisión
Seguir

Olanib 150 mg (Olaparib)

Comunidad

SECTORES

WEB OFICIAL

Sobre Olanib 150 mg (Olaparib)

Olanib 150 mg, containing the active ingredient olaparib, is a targeted cancer therapy primarily used for treating specific types of ovarian, breast, pancreatic, and prostate cancers. Olaparib belongs to a class of drugs known as PARP inhibitors, which work by preventing cancer cells from repairing their DNA, leading to cell death. It's particularly effective in patients with BRCA1 or BRCA2 gene mutations. The medication is typically administered orally and requires careful monitoring for potential side effects, including nausea, fatigue, anemia, and leukopenia. Regular follow-ups with a healthcare provider are crucial to ensure optimal treatment outcomes and manage any adverse effects.

Galería Olanib 150 mg (Olaparib) 0

Olanib 150 mg (Olaparib) no tiene ninguna imágen en su galería.

Datos Olanib 150 mg (Olaparib)

Oficinas
Localizaciones

Equipo Olanib 150 mg (Olaparib) 1

Noticias Olanib 150 mg (Olaparib) 0

Olanib 150 mg (Olaparib) no tiene ninguna noticia disponible.

Política de Cookies Utilizamos cookies propias y de terceros para mejorar nuestros servicios y la experiencia de usuario. Si continúa navegando, consideramos que acepta su uso.

Aceptar